Filing Details
- Accession Number:
- 0001179110-18-011271
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-11 13:36:10
- Reporting Period:
- 2018-09-07
- Accepted Time:
- 2018-09-11 13:36:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1537768 | A. Daniel Macuga | 3838 West Parkway Blvd. Salt Lake City UT 84120 | Chief Communications Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-09-07 | 5,204 | $70.75 | 5,204 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-07 | 1,446 | $124.07 | 3,758 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-09-07 | 3,758 | $125.51 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-09-10 | 2,907 | $70.75 | 2,907 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-10 | 2,907 | $126.01 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-09-10 | 2,549 | $70.75 | 2,549 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-10 | 2,549 | $125.53 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock - Settled Stock Appreciation Rights | Disposition | 2018-09-07 | 12,118 | $0.00 | 12,118 | $70.75 |
| Common Stock | Stock - Settled Stock Appreciation Rights | Disposition | 2018-09-10 | 6,629 | $0.00 | 6,629 | $70.75 |
| Common Stock | Stock - Settled Stock Appreciation Rights | Disposition | 2018-09-10 | 5,873 | $0.00 | 5,873 | $70.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 45,502 | 2018-09-01 | 2020-03-01 | No | 4 | M | Direct |
| 38,873 | 2018-09-01 | 2020-03-01 | No | 4 | M | Direct |
| 33,000 | 2018-09-01 | 2020-03-01 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II
- Weighted average price $124.07. Price range in multiple transactions was $124.00 to $124.65 inclusively.
- Weighted average price $125.509. Price range in multiple transactions was $125.00 to $125.70 inclusively.
- Weighted average price $126.012. Price range in multiple transactions was $126.00 to $126.125 inclusively.
- Weighted average price $125.534. Price range in multiple transactions was $125.00 to $125.75 inclusively.
Billionaire Hedge Funds
